Gene-Guided dosing aims to improve kidney transplant success
NCT ID NCT06701825
Summary
This study is testing whether checking a patient's genes before a kidney transplant can help doctors prescribe the correct starting dose of a crucial anti-rejection drug called tacrolimus. It will compare this genetic-guided approach to the current standard of care to see if it gets patients to the right drug level faster, reduces side effects, and is cost-effective. The trial involves 114 adults in Spain who are on the waiting list for a kidney transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital La Paz
RECRUITINGMadrid, Madrid, 28046, Spain
Contact
Conditions
Explore the condition pages connected to this study.